Association of Metabolic Genotype Composite CYP3A5*3 and CYP3A4*1B to Tacrolimus Pharmacokinetics in Stable Black and White Kidney Transplant Recipients. [PDF]
Brazeau D +7 more
europepmc +1 more source
Refining tacrolimus dosing through CYP3A5 pharmacogenetics in Taiwanese renal transplant recipients. [PDF]
Chang YL +7 more
europepmc +1 more source
Impact of and Polymorphisms on Imatinib Mesylate Response Among Chronic Myeloid Leukemia Patients in Malaysia [PDF]
core +1 more source
Implications of Genetic Elements on Type 2 Diabetes Mellitus Pathogenesis and Management. [PDF]
Ngcobo NN, Sibiya NH.
europepmc +1 more source
Association between tacrolimus intrapatient variability and clinical outcomes in kidney transplantation: a retrospective cohort study. [PDF]
Chen H +5 more
europepmc +1 more source
Prevalence of actionable pharmacogenomic variants in Brazilian patients with cancer. [PDF]
Schuch JB +28 more
europepmc +1 more source
Single-nucleotide polymorphisms of donor <i>CYP3A5</i> and recipient <i>ABCB1</i> affect tacrolimus intrapatient variability in living donor liver transplantation: a retrospective cohort study. [PDF]
Gongor SO +8 more
europepmc +1 more source
Optimizing Dose Conversion from IR-Tac to LCP-Tac Formulations in Renal Transplant Recipients: A Population Pharmacokinetic Modeling Study. [PDF]
Mohammed Ali Z +13 more
europepmc +1 more source
Pharmacogenomics of direct oral anticoagulants: a systematic review and meta-analysis. [PDF]
Chai H, Huo J, Chen H.
europepmc +1 more source
Population pharmacokinetic characteristics of tacrolimus in Chinese lung transplant recipients and optimisation of dosing regimen during the early post-transplantation phase. [PDF]
Zhou S +7 more
europepmc +1 more source

